Medicare
News, insights and expert analysis on medicare from the team at Kiplinger.
Donna LeValley
Latest
-
Five Reasons Why You Should Review Your Medicare Advantage Plan Before Open Enrollment Ends
Medicare Advantage enrollees have until March 31 to make changes to their selections.
By Donna LeValley Published
-
Don't Let Health Care Costs Wreck Your Retirement: Here's How
Four strategies to keep health care costs from tanking your retirement, especially before Medicare kicks in.
By Maurie Backman Published
-
Five Retirement Myths vs the Reality
Believing these myths about retirement could set you down the wrong path. Separating fact from fiction can help you approach your retirement with confidence.
By Tony Drake, CFP®, Investment Advisor Representative Published
-
How to Support Your Parents Without Derailing Your Finances
Putting your aging parents' financial house in order can give you a clearer picture of where they need support and how to balance that with your own plans.
By Vincent Birardi, CFP®, AIF®, MBA Published
-
What You Need to Know About Elon Musk's DOGE's Access to Medicare Systems
Officials at Musk-led DOGE were given access to agency data systems and technology at the Centers for Medicare and Medicaid Services (CMS), an agency with a $2 trillion budget.
By Kathryn Pomroy Last updated
-
Compare Prior Authorization Denial Rates of Medicare Advantage Plans
Will your care be denied? Medicare Advantage insurers use prior authorization to manage utilization and lower costs. How does your plan measure up?
By Donna LeValley Published
-
RFK Jr. Confused Medicare and Medicaid: Here's the Difference
The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them. We break down the difference.
By Maurie Backman Last updated
-
What a Federal Grants Pause Could Have Meant for Social Security and Medicare
The White House rescinded a pause on all Federal grants and loans after an outcry, but the short-lived action shined a light on what could come in the future.
By Donna Fuscaldo Last updated
-
Medicare Price Negotiations To Continue Under the Trump Administration
The Centers for Medicare & Medicaid Services plans to negotiate the prices for 15 new drugs, although it says its seeking "greater transparency" in price talks.
By Donna Fuscaldo Last updated